Postpoliomyelitis Syndrome

Also known as: Post-Poliomyélitis Syndrom / Post-Poliomyelitis Syndrome / Postpolio Syndrome / Post Polio Syndrome, PPS / Post polio syndrome / Post-Polio Syndrome / Post poliomyelitis syndrome (disorder)

DrugDrug NameDrug Description
DB00545PyridostigmineA cholinesterase inhibitor used for symptomatic treatment of myasthenia gravis and congenital myasthenic syndromes and to reverse neuromuscular blockade by nondepolarizing muscle relaxants.
DrugDrug NamePhaseStatusCount
DB00028Human immunoglobulin G2 / 3Terminated1
DB00155Citrulline3Completed1
DB00028Human immunoglobulin G3Completed1
DB00583Levocarnitine3Withdrawn1
DB00745Modafinil3Terminated1
DB09210Piracetam3Withdrawn1